ArticleFrontiers in neurology2025
Association between anesthetics and the postoperative pneumonia risk in patients with non-traumatic subarachnoid hemorrhage: an analysis of the MIMIC-IV database.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Postoperative pneumonia (POP) is a common complication in surgical patients. The choice of anesthetic may affect POP in patients with non-traumatic subarachnoid hemorrhage (SAH). This study aims to identify a key anesthetic as an independent predictor for POP risk in patients with non-traumatic SAH. Methods: This retrospective study utilized data from the MIMIC-IV database spanning the period from 2008 to 2019. First, receiver operating characteristic (ROC) curve analysis, decision curve analysis, and factor importance analysis were conducted to determine which anesthetic was more effective and important in predicting POP in patients with non-traumatic SAH. Second, three different multivariate logistic regression models were established to investigate the association between fentanyl use and the risk of POP, followed by subgroup analysis. Finally, a series of comparative analyses were conducted between fentanyl and traditional disease severity scores. Results: Fentanyl (AUC: 0.680) demonstrated a significantly higher predictive value than propofol (AUC: 0.604), midazolam (AUC: 0.608), and dexmedetomidine (AUC: 0.630) in predicting POP in patients with non-traumatic SAH (all Delong test Conclusion: Our findings indicated that fentanyl was associated with POP and may serve as a robust predictor of POP risk in patients with non-traumatic SAH.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.